[1]林晓岚,陈苑莉.慢性乙型肝炎患者治疗依从性及其对生活质量的影响[J].医学信息,2018,31(13):168-170.[doi:10.3969/j.issn.1006-1959.2018.13.052]
　LIN Xiao-lan,CHEN Yuan-li.Treatment Compliance of Patients with Chronic Hepatitis B and its Influence on Quality of Life[J].Journal of Medical Information,2018,31(13):168-170.[doi:10.3969/j.issn.1006-1959.2018.13.052]
点击复制

慢性乙型肝炎患者治疗依从性及其对生活质量的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年13期
页码:
168-170
栏目:
护理研究
出版日期:
2018-07-01

文章信息/Info

Title:
Treatment Compliance of Patients with Chronic Hepatitis B and its Influence on Quality of Life
文章编号:
1006-1959（2018）13-0168-03
作者:
林晓岚; 陈苑莉
中山大学附属第三医院感染性疾病科，广东 广州 510630
Author(s):
LIN Xiao-lan; CHEN Yuan-li
Department of Infectious Diseases,Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,Guangdong,China
关键词:
慢性乙型肝炎; 治疗依从性; 生活质量
Keywords:
Key words：Chronic hepatitis B; Treatment compliance; Quality of life
分类号:
R473.5
DOI:
10.3969/j.issn.1006-1959.2018.13.052
文献标志码:
A
摘要:
目的 探讨慢性乙型肝炎患者抗病毒治疗的依从性及其与生活质量的关系。方法 采用治疗依从性调查问卷和慢性肝病问卷对154例纳入研究的住院慢性乙型肝炎患者进行横断面调查。结果 154例患者中有127例患者进行抗病毒治疗，用药依从性好占66.93%，定期复查的依从性好占75.97%，按时作息的依从性好占81.82%，不饮酒的依从性好占88.96%。用药依从性好的患者生活质量在各维度的得分均高于依从性差的患者，在腹部症状、全身症状、活动维度的得分差异有统计学意义（P＜0.05），在乏力、情感功能、焦虑维度的得分差异无统计学意义（P＞0.05）。结论 医务工作者需要关注慢性乙型肝炎患者抗病毒治疗的依从性，患者用药的依从性与生活质量相关，提高治疗依从性可以改善患者的生活质量。
Abstract:
Abstract：Objective To investigate the compliance of antiviral therapy in patients with chronic hepatitis B and its relationship with quality of life.Methods 154 hospitalized patients with chronic hepatitis B were investigated by therapeutic compliance questionnaire and chronic liver disease questionnaire.Results 127 of 154 patients were treated with antiviral therapy.Good compliance of drug use was 66.93%,good compliance of regular reexamination was 75.97%,good compliance of working and rest on time was 81.82%,good compliance of non-drinking was 88.96%.The scores of quality of life of patients with good compliance were higher than those of patients with poor compliance.There were significant differences in abdominal symptoms,systemic symptoms and activity dimensions(P <0.05).There was no significant difference in the scores of asthenia,emotional function and anxiety dimension(P>0.05).Conclusion Medical workers need to pay attention to the compliance of antiviral therapy in patients with chronic hepatitis B.The compliance of patients with drugs is related to the quality of life improving the compliance of treatment can improve the quality of life of patients.

参考文献/References:

[1]尤黎明,吴瑛.内科护理学[M].第6版.北京:人民卫生出版社,2017. [2]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015 更新版)[J].中华临床感染病杂志,2015,8(6):481-503. [3]汤伯宗,潘奇,陆云飞,等.抗病毒治疗对乙型肝炎病毒相关慢加急性肝衰竭患者预后的影响[J].临床肝胆病杂志,2012(28):748-751. [4]庄辉,翁心华.核苷(酸)类似药物治疗慢性乙型肝炎停药的探讨[J].中国病毒病杂志,2013,3(4):241-244. [5]吴创鸿,邓启文,纪晓抒,等.慢性肝病问卷在慢性乙型肝炎患者中的试用[J].中国临床心理学杂志,2003,11(1):60-62. [6]《中国肝病诊疗管理规范》白皮书（节选）[J].临床肝胆病杂志,2014,30(3):197-209. [7]关玉华,王建红.自我管理教育在提高慢性乙型病毒性肝炎患者治疗依从性中的作用[J].现代医药卫生,2011,27(11):1721-1722. [8]张燕,王全楚.慢性乙型肝炎抗病毒治疗进展[J].胃肠病学和肝病学杂志,2012,21(10):897-900. [9]朱丽君,陈建杰,成扬.认知行为干预对慢性乙型肝炎病人遵医行为及生存质量的影响[J].护理研究,2016,30(9):3234-3237.

相似文献/References:

[1]林晓岚,郑丽花,陈苑莉,等.微信随访对慢性乙型肝炎患者抗病毒治疗效果和 生活质量的影响研究[J].医学信息,2018,31(10):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
　LIN Xiao-lan,ZHENG Li-hua,CHEN Yuan-li,et al.Effect of WeChat Follow-up on Antiviral Treatment and Quality of Life in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2018,31(13):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
[2]钟纯洁.长沙市某社区老年高血压患者治疗依从性调查分析[J].医学信息,2018,31(14):81.[doi:10.3969/j.issn.1006-1959.2018.14.023]
　ZHONG Chun-jie.Investigation and Analysis of Treatment Compliance of Elderly Hypertensive Patients in a Community in Changsha City[J].Journal of Medical Information,2018,31(13):81.[doi:10.3969/j.issn.1006-1959.2018.14.023]
[3]陈 欢,李秀惠.急、慢性乙型肝炎及乙肝肝硬化患者 肝功能及血脂水平分析[J].医学信息,2019,32(12):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
　CHEN Huan,LI Xiu-hui.Analysis of Liver Function and Blood Lipid Levels in Patients with Acute, Chronic Hepatitis B and Hepatitis B Cirrhosis[J].Journal of Medical Information,2019,32(13):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
[4]吴 刚,吴锦瑜.HBeAg阴性慢性乙型肝炎患者血清25-羟基维生素D3的检测及临床意义[J].医学信息,2018,31(19):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
　WU Gang,WU Jin-yu.Detection and Clinical Significance of Serum 25-hydroxyvitamin D3 in Patients with HBeAg-negative Chronic Hepatitis B[J].Journal of Medical Information,2018,31(13):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
[5]叶向荣.恩替卡韦治疗慢性乙型肝炎病毒感染的临床价值评价[J].医学信息,2018,31(22):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
　YE Xiang-rong.Clinical Evaluation of Entecavir in Treatment of Patients with Chronic Hepatitis B Virus Infection[J].Journal of Medical Information,2018,31(13):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
[6]汪晓凤,邵和军.慢性乙型肝炎抗病毒治疗进展[J].医学信息,2019,32(04):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
　WANG Xiao-feng,SHAO He-jun.Progress in Antiviral Therapy for Chronic Hepatitis B[J].Journal of Medical Information,2019,32(13):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
[7]傅 蕊,李士欣,周国强,等.床旁超声预测慢性乙型肝炎患者胃镜检查围麻醉期误吸风险的临床价值[J].医学信息,2019,32(08):123.[doi:10.3969/j.issn.1006-1959.2019.08.035]
　FU Rui,LI Shi-xin,ZHOU Guo-qiang,et al.Clinical Value of Bedside Ultrasound in Predicting the Risk of Aspiration during Perioperative Anesthesia in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2019,32(13):123.[doi:10.3969/j.issn.1006-1959.2019.08.035]
[8]张媛媛,徐 曼.慢性乙型肝炎患者e抗原消失的临床特点[J].医学信息,2019,32(10):105.[doi:10.3969/j.issn.1006-1959.2019.10.033]
　ZHANG Yuan-yuan,XU Man.Clinical Features of e Antigen Disappearance in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2019,32(13):105.[doi:10.3969/j.issn.1006-1959.2019.10.033]
[9]罗 丹,梁惠卿,吴耀南.吴耀南教授基于“伏邪”理论治疗慢性乙肝的验案举隅[J].医学信息,2019,32(19):158.[doi:10.3969/j.issn.1006-1959.2019.19.052]
[10]周腾腾,郑 莹,梁恵卿,等.蛋白质组学在慢性乙型肝炎常见中医证型中的研究[J].医学信息,2019,32(20):30.[doi:10.3969/j.issn.1006-1959.2019.20.009]
　ZHOU Teng-teng,ZHENG Ying,LIANG Hui-qing,et al.Study on Proteomics in Common TCM Syndromes of Chronic Hepatitis B[J].Journal of Medical Information,2019,32(13):30.[doi:10.3969/j.issn.1006-1959.2019.20.009]

更新日期/Last Update: 2018-07-01